MAPT and Alzheimer disease: Loss in synapses, amyloid β (Aβ) peptide aggregation and accumulation of tau neurofibrillary tangles into specific Central Nervous System (CNS) regions are mainly required for AD diagnosis (Galasko and Shaw, 2017; Jack et al., 2017).